Darius Pharmaceuticals Private Limited

Darius Pharmaceuticals Private Limited - trading in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U51909MH2019PTC330003 Incorporated 30 August 2019 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company trading
Revenue · FY 2025
₹21.51 Lakh
▲ 9% YoY
Net profit · FY 2025
₹53,544
Net margin 2.5%
EBITDA · FY 2025
₹78,513
EBITDA margin 3.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Darius Pharmaceuticals Private Limited

Data last updated:

Darius Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 30 August 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51909MH2019PTC330003. Its GSTIN is 10AAHCD4073C1ZA (Bihar).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kumar and Arti Kumari.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O M/S Giriraj Construction Wing 103 Build – A 103 Ambadi Road Vasai Navghar, Mumbai, Maharashtra, India – 401202.

As per the financials filed for FY 2025, the company reported a revenue of ₹21.51 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹53,544 (net margin 2.5%) and EBITDA of ₹78,513 (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 62% over five years.

Company details

CIN U51909MH2019PTC330003
Registration Number 330003
Incorporation Date 30 August 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active

Contact details

Darius Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C/O M/S Giriraj Construction Wing 103 Build – A 103 Ambadi Road Vasai Navghar, Mumbai, Maharashtra, India – 401202
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Darius Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Darius Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Darius Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Darius Pharmaceuticals Private Limited, buy the company report.

Financials of Darius Pharmaceuticals Private Limited

FY 2025 filings available

Darius Pharmaceuticals Private Limited reported revenue of ₹21.51 Lakh (up 9% YoY) for FY 2025.

Revenue · FY 2025
₹21.51 Lakh ▲ 9%
Net profit · FY 2025
₹53,544 margin 2.5%
EBITDA · FY 2025
₹78,513 margin 3.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 26%
5 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 22%
5 years · compounded
▼ 14%

Revenue has grown at a compounded annual rate (CAGR) of 62% over five years, including 9% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹78,513
Profit Before Tax
Tax Expense
Net Profit (PAT)₹53,544
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.7%
Net Profit Margin2.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Darius Pharmaceuticals Private Limited, buy the company report.

Board of directors of Darius Pharmaceuticals Private Limited

Darius Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
KumarDirector14 Jan 20224 Years 10 MonthsCurrent
Arti KumariDirector30 Aug 20197 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Darius Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Darius Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAHCD4073C1ZABiharActive11 Oct 2019

To see the full GST registrations and return filing status of Darius Pharmaceuticals Private Limited, buy the company report.

Recent activity

Darius Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Kumar ceased to be Additional Director on 07 Sep 2022.

AGM
Darius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Darius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Kumar ceased to be Additional Director.
Appointed
Kumar was appointed as Director.
Ceased
Kumari Pratibha Singh ceased to be Director.
Appointed
Arti Kumari was appointed as Director.
Incorporation
30 Aug 2019
Darius Pharmaceuticals Private Limited was registered on 30 Aug 2019 with Roc Mumbai I & aged 7 years 2 months as per MCA records.

Frequently asked questions

Darius Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in specialty, within the trading industry. It was incorporated on 30 August 2019 (7+ years old) and is registered under CIN U51909MH2019PTC330003.

Darius Pharmaceuticals has 2 current directors:

The latest financial statements of Darius Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Darius Pharmaceuticals is 10AAHCD4073C1ZA, registered in Bihar.

The CIN (Corporate Identification Number) of Darius Pharmaceuticals is U51909MH2019PTC330003. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Darius Pharmaceuticals was incorporated on 30 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.

Kumar ceased to be Additional Director on 07 Sep 2022. Kumar was appointed as Director on 14 Jan 2022. Kumari Pratibha Singh ceased to be Director on 14 Jan 2022. Darius Pharmaceuticals has 4 board changes on record in total.

The registered office of Darius Pharmaceuticals is at CO MS Giriraj Construction Wing 103 Build – A 103 Ambadi Road Vasai Navghar, Mumbai, Maharashtra, India – 401202.

Darius Pharmaceuticals operates in the trading industry, in the specialty segment.

Darius Pharmaceuticals can be reached at its registered office: CO MS Giriraj Construction Wing 103 Build – A 103 Ambadi Road Vasai Navghar, Mumbai, Maharashtra, India – 401202.